Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase‐associated neurodegeneration
暂无分享,去创建一个
Ji-feng Guo | Kun Xia | K. Xia | B. Tang | Ji-feng Guo | S. Westaway | S. Hayflick | Susan J Hayflick | Shawn K Westaway | Yu-hu Zhang | Yu-hu Zhang | Bei-sha Tang | Ai-ling Zhao | Zhi-gao Long | Z. Long | Ai-ling Zhao
[1] J. Gitschier,et al. Mitochondrial Localization of Human PANK2 and Hypotheses of Secondary Iron Accumulation in Pantothenate Kinase‐Associated Neurodegeneration , 2004, Annals of the New York Academy of Sciences.
[2] S. Hayflick. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase–associated neurodegeneration is the name . . . , 2003, Current opinion in pediatrics.
[3] B. Levinson,et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.
[4] Shawn K. Westaway,et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.
[5] E. Dooling,et al. Hallervorden-Spatz syndrome. , 1974, Archives of neurology.
[6] K F Swaiman,et al. Hallervorden-Spatz syndrome and brain iron metabolism. , 1991, Archives of neurology.
[7] T. Taylor,et al. Homozygosity mapping of Hallervorden–Spatz syndrome to chromosome 20p12.3–p13 , 1996, Nature Genetics.
[8] C. Woods,et al. Karak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum , 2003, Journal of medical genetics.
[9] K. Swaiman. Hallervorden-Spatz syndrome. , 1990, Pediatric neurology.
[10] S. Hayflick. Pantothenate kinase-associated neurodegeneration (formerly Hallervorden–Spatz Syndrome) , 2003, Journal of the Neurological Sciences.